Patent Number: 6,165,491

Title: Pharmaceutical composition based on estrogen and progesterone

Abstract: A pharmaceutical composition, intended for menopausal replacement therapy, comprising a suspension of progesterone in a lipophilic medium solution of a 17-estradiol salt in the lipophilic medium, the weight ratio of progesterone to the base 17-estradiol being 25 to 600.

Inventors: Grasset; Etienne (Boulogne, FR), Terracol; Didier (Verrieres le Buisson, FR), Galdona; Javier Gil (Madrid, ES)

Assignee: Effik SCA BAT

International Classification: A61K 9/48 (20060101); A61K 31/57 (20060101); A61F 006/06 (); A61F 013/02 (); A61K 009/48 ()

Expiration Date: 12/26/2013